Skip to main content

19 May 2026 - Innovation in the NHS: personalised medicine and AI - Oral evidence

Committee Science and Technology Committee
Inquiry Innovation in the NHS: personalised medicine and AI

Tuesday 19 May 2026

Start times: 10:00am (private) 10:15am (public)


Add to calendar

Meeting details

At 10:15am: Oral evidence
Inquiry Innovation in the NHS: personalised medicine and AI
Chief Executive Officer at Autolus Therapeutics
Chief Executive Officer at Genomics Ltd
At 11:15am: Oral evidence
Inquiry Innovation in the NHS: personalised medicine and AI
Chief Executive Officer and Co-Founder at Brainomix
Chief Executive Officer at Scancell

Location

Room 2, Palace of Westminster

How to attend